Frontiers in Psychiatry | Mood Disorders

Correction

Published on 28 Oct 2024

Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

in Mood Disorders

Magdalena Więdłocha
Piotr Marcinowicz
Jan Komarnicki
Małgorzata Tobiaszewska
Weronika Dębowska
Marta Dębowska
Agata Szulc

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1507504

712 views

Original Research

Published on 17 Oct 2024

When you avoid your feelings, you may feel even worse: how depersonalization puts you at risk of depression

in Mood Disorders

Dominika Fortuna
Krystyna Golonka

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1481439

1,372 views

Original Research

Published on 17 Oct 2024

Prediction of pharmacological treatment efficacy using electroencephalography-based salience network in patients with major depressive disorder

in Mood Disorders

Kang-Min Choi
Taegyeong Lee
Chang-Hwan Im
Seung-Hwan Lee

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1469645

981 views

Original Research

Published on 15 Oct 2024

Cognitive function characteristics and influencing factors in patients with depressive disorders: a 5-year follow-up report based on the epidemiological survey of mental disorders in Shandong Province, China

in Mood Disorders

Ziang Lin
Qian Wang
Xiaojing Li
Can Wang
Ruzhan Wang
Chenghui Wang
Hao Ding
Liju Qian
Xiaona Wan
Xue Tian

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1434659

710 views

Original Research

Published on 14 Oct 2024

The impact of sleep disturbances on treatment efficacy and prognosis in patients with depressive and anxiety disorders

in Mood Disorders

Qingyu Zhang
Maoqing Tong
Yunxin Ji
Yanbin Hou
Zongze Lou
Danjuan Wu
Yuwei Mi
Pingping Miu
Jiaxin Tian
Zhenzhen Zhu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1432538

1,178 views

Review

Published on 14 Oct 2024

From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression

in Mood Disorders

Aleksandra Kupferberg
Gregor Hasler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1372650

3,023 views

Original Research

Published on 10 Oct 2024

The association between borderline personality disorder, childhood trauma, neuroticism, and self-rated or clinician-rated functional impairment in euthymic bipolar disorder-1 patients

in Mood Disorders

Esat Fahri Aydın
Tuğba Koca Laçin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1444583

1,330 views

Original Research

Published on 10 Oct 2024

Higher atherogenic index of plasma is associated with increased major depressive disorder: insights from a nationally representative study

in Mood Disorders

Shiyi Tao
Lintong Yu
Jun Li
Xuanchun Huang
Tiantian Xue
Deshuang Yang
Yuqing Tan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1441119

1,513 views

Original Research

Published on 07 Oct 2024

Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study

in Mood Disorders

Albino J. Oliveira-Maia
Benoît Rive
Yordan Godinov
Siobhán Mulhern-Haughey

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1459633

1,222 views

Review

Published on 03 Oct 2024

Efficacy of bifidobacterium-related preparations on depression: the first meta-analysis

in Mood Disorders

Ruihan Huang
Yongsheng Liu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1463848

1,026 views

Original Research

Published on 03 Oct 2024

Negative interaction between emotional vulnerability and depressive symptoms may heighten suicidal ideation among Japanese university students: a cross-sectional study

in Mood Disorders

Shinji Yamaguchi
Daiki Nagamine
Yuka Murofushi
Kojiro Matsuda

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1383907

1,072 views

Original Research

Published on 30 Sep 2024

Stressors during the prodromal phase of major depressive episode (CHR-D)

in Mood Disorders

Eva Meisenzahl
Frauke Schultze-Lutter
Veronika Stegmüller
Gerd Schulte-Körne
Ellen Greimel
Cosima Klingele
Udo Dannlowski
Tim Hahn
Georg Romer
Marcel Romanos

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1389370

748 views

Review

Published on 24 Sep 2024

The major biogenic amine metabolites in mood disorders

in Mood Disorders

Jingyi Yang
Minlan Yuan
Wei Zhang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1460631

1,064 views

Systematic Review

Published on 23 Sep 2024

Psilocybin for major depressive disorder: a systematic review of randomized controlled studies

in Mood Disorders

Li-Juan Li
Yu Mo
Zhan-Ming Shi
Xing-Bing Huang
Yu-Ping Ning
Hua-Wang Wu
Xin-Hu Yang
Wei Zheng

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1416420

3,117 views
1 citation

Original Research

Published on 23 Sep 2024

Effect of sleep quality on repetitive transcranial magnetic stimulation outcomes in depression

in Mood Disorders

Jamie Kweon
Andrew M. Fukuda
Asi P. Gobin
Lamaan Haq
Linda L. Carpenter
Joshua C. Brown

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1458696

1,588 views

Original Research

Published on 20 Sep 2024

Predictors of depression among caregivers of patients with severe mental illness in Northwest Ethiopia, 2023: an explanatory sequential mixed-method study

in Mood Disorders

Birhanu Mengist Munie
Zelalem Birhan
Getasew Legas
Sintayehu Asnakew
Amsalu Belete
Getnet Mihretie Beyene
Kirubel Shiferaw
Anemut Tilahun Mulu
Yohannes Tesfahun Kassie
Tigabu Munye Aytenew

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1422104

1,206 views

Navigation group

Articles

Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

When you avoid your feelings, you may feel even worse: how depersonalization puts you at risk of depression

Prediction of pharmacological treatment efficacy using electroencephalography-based salience network in patients with major depressive disorder

Cognitive function characteristics and influencing factors in patients with depressive disorders: a 5-year follow-up report based on the epidemiological survey of mental disorders in Shandong Province, China

The impact of sleep disturbances on treatment efficacy and prognosis in patients with depressive and anxiety disorders

From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression

The association between borderline personality disorder, childhood trauma, neuroticism, and self-rated or clinician-rated functional impairment in euthymic bipolar disorder-1 patients

Higher atherogenic index of plasma is associated with increased major depressive disorder: insights from a nationally representative study

Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study

Efficacy of bifidobacterium-related preparations on depression: the first meta-analysis

Negative interaction between emotional vulnerability and depressive symptoms may heighten suicidal ideation among Japanese university students: a cross-sectional study

Stressors during the prodromal phase of major depressive episode (CHR-D)

The major biogenic amine metabolites in mood disorders

Psilocybin for major depressive disorder: a systematic review of randomized controlled studies

Effect of sleep quality on repetitive transcranial magnetic stimulation outcomes in depression

Predictors of depression among caregivers of patients with severe mental illness in Northwest Ethiopia, 2023: an explanatory sequential mixed-method study